(Q33703136)

reason for preferred rank

28 July 2017

title

Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009 (English)

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.09.020

20 July 2024

Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869467

Vaccine Adverse Event Reporting System

20 July 2024

main subject

Guillain–Barré syndrome

0 references

1 reference

based on heuristic

inferred from title

vaccine adverse event

1 reference

1 reference

7

Adnan I. Qureshi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869467

20 July 2024

author name string

Nizar Souayah

1

1 reference

28 July 2017

Abu Nasar

3

1 reference

28 July 2017

Nataliya Krivitskaya

4

1 reference

28 July 2017

Hafiz Khan

6

1 reference

28 July 2017

P. A. Michas-Martin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869467

20 July 2024

Hussam A. Yacoub

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20869467

20 July 2024

language of work or name

English

0 references

publication date

23 September 2010

1 reference

full work available at URL

28 July 2017

https://api.elsevier.com/content/article/PII:S0264410X10013307?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.09.020

https://api.elsevier.com/content/article/PII:S0264410X10013307?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.09.020

20 July 2024

1 reference

28 July 2017

volume

29

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

886-889

1 reference

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Guillain-Barré syndrome following influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

A prospective study of acute idiopathic neuropathy. II. Antecedent events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Influenza vaccination and Guillain Barre syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Cervical cancer vaccination indications, efficacy, and side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Neurological adverse events associated with vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

An uncommon cause of lower limb weakness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Central nervous system disease in patients with macrophagic myofasciitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.020

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

7 January 2021

2

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.09.020

20 July 2024

Identifiers

1 reference

28 July 2017

1 reference